Eysenck HJ. An exercise in mega-silliness. Am Psychol1978; 33: 517.
3.
Oxman A, Cook D, Guyatt G for the evidencebased medicine working group. Users guide to the medical literature. vi: How to use an overview. JAMA1994; 272: 1367–1371.
4.
Baily KR. Inter-study differences: how should they influence the interpretation and analysis of results?Stat Med1987; 6: 351–358.
5.
Yusef S, Peto R, Lewis J, Collins R, Sleight P. Beta blockage during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovas Dis1985; 17: 335–371.
6.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials1986; 7: 177–188.
7.
Egger M, Davey Smith G, Philips A. Meta-analysis. Principles and procedures. BMJ1997; 315: 1533–1537.
8.
McQuay HJ, Moore RA, Eccleston C, Morley S, de C Williams AC. Systematic review of outpatient services for chronic pain control. Health Technol Assess1997; 1.
9.
Greenhalgh T. Papers that summarise other papers (systematic reviews and meta-analyses). BMJ1997; 315: 672–675.
10.
Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel J-P. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ1992; 305: 913–920.
11.
Nurmohamed MT, Rosendaal FR, Bueller HR et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet1992; 340: 152–156.
12.
Linde K, Clausius N, Ramirez G et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet1997; 350: 834–841.
13.
Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ1991; 303: 1499–1503.
14.
Hardy JR. Placebo-controlled trials in palliative care: the argument for. Palliat Med1997; 11: 415–418.
15.
Kirkham SR, Abel J. Placebo-controlled trials in palliative care: the argument against. Palliat Med1997; 11: 489–492.
